Inflation data dominates in the coming week. Clearly, at present the quarterly data on price changes doesn’t rank highly. Instead, most investors and analysts are dissecting the effects of COVID-19 on the economy.
Inflation data dominates in the coming week. Clearly, at present the quarterly data on price changes doesn’t rank highly. Instead, most investors and analysts are dissecting the effects of COVID-19 on the economy.
Australian company Speedcast goes into bankruptcy, shares in Gilead Sciences drop after COVID-19 drug fails, the PM calls out the 'Big Four' banks to continue helping businesses ahead of Job Keeper and MORE.
Joining Peter Switzer this week: Tim Lawless, Rich Harvey and Tommy Wu.
With the Coronavirus and the threat to the economy, the silliest step we could take would be to worry about what economists want. We need real world people.
Cochlear was one of the first ASX-listed companies to engage in capital raising, which has both institutional and retail shareholders asking a lot of questions.
Elmo is a rapidly growing HR Tech company providing cloud HR, payroll, rostering and attendance management technology to approximately 1,478 companies primarily throughout Australia and New Zealand.
Oil and gold have both jumped overnight, with Wall Street closing on a high, expecting the ASX to open on a high. The WHO pleads with the US and MORE.
For the 100th episode of The Switzer Show, Peter Switzer and Paul Rickard are joined by Magellan's Hamish Douglass, Dr Ross Walker and AMP Capital's Shane Oliver.
The Coronavirus could soon spark a taxing ageist national debate over who should pay for the Government’s rescue plan.
Fill in the form below to subscribe to Switzer Daily and get our latest articles, videos and podcasts sent straight to your inbox